UPDATE 2-Small relief for Biogen in MS drug approval
October 30, 2019 at 09:56 AM EDT
The U.S. Food and Drug Administration on Wednesday approved Biogen Inc's new oral drug to treat multiple sclerosis, offering the drugmaker some relief as its core franchise faces patent challenges.